Immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment


For many patients with a condition that often precedes multiple myeloma, early treatment can slow or delay the progression to myeloma. In a new study, investigators at Dana-Farber Cancer Institute demonstrate that changes in immune system cells can indicate which patients with high-risk “smoldering” myeloma are likely to progress to myeloma and which will benefit the most from treatment.

10 years later, the Candle Queen of Appleton wouldn’t change anything about her viral Bath & Body Works rant

Previous article

Restorative neurostimulation continues to be effective in treating low-back pain for three years

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations